1. ALLA AKTIER
  2. NYHETER
  3. SCANDINAVIAN REAL HEART

Scandinavian Real Heart

Nyheter Scandinavian Real Heart Nyheter alla bolag

Realheart Receives EUR 250,000 in Third Grant Payment From the European Innovation Council

Västerås, Sweden, August 11, 2025 – Scandinavian Real Heart AB (publ) announces today that the company has received its third disbursement from the European Innovation Council (EIC) grant, initially awarded in December 2021. The grant aims to support the development of the artificial heart Realheart® TAH. The payment of EUR 250,000 equals 10% of the total grant sum of EUR 2.5 million.

The company was awarded a EUR 2.5 million grant within the framework of the European Innovation Council Accelerator program, aimed at supporting European innovations that have the potential to create new markets or disrupt existing ones. The grant continues to serve as a valuable mark of excellence that has enhanced the company's international standing among distinguished clinics and industry experts.

“We’re glad to receive the third disbursement from the European Innovation Council as part of its support for the development of Realheart® TAH. The funds will be used as part of our current efforts to further improve our quality workflows and accelerate production capabilities,” says Ina Laura Perkins, CEO, Realheart.

For more information, please contact:
Ina Laura Perkins, CEO
Phone: +46 (0) 70 406 49 21 
E-mail: inalaura.perkins@realheart.se
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se

About Us
Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. Realheart® TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trials ahead of a first clinical study in patients. The company's shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit www.realheart.se

Attachments
Realheart Receives EUR 250,000 in Third Grant Payment From the European Innovation Council

Datum 2025-08-11, kl 09:15
Källa MFN
Bifogade filer
Realheart Receives EUR 250,000 in Third Grant Payment From the European Innovation Council
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.